These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 1538028

  • 21. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.
    Golino P, Ashton JH, Buja LM, Rosolowsky M, Taylor AL, McNatt J, Campbell WB, Willerson JT.
    Circulation; 1989 Jan; 79(1):154-66. PubMed ID: 2910540
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The effect of selective serotonin administration into different portions of the coronary vascular bed on the retrograde (collateral) coronary blood flow in myocardial ischemia in dogs].
    Azarov VI, Hrabovs'kyĭ LO, Moĭbenko OO.
    Fiziol Zh (1994); 1999 Jan; 45(1-2):26-34. PubMed ID: 10202633
    [Abstract] [Full Text] [Related]

  • 24. Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise.
    Traverse JH, Altman JD, Kinn J, Duncker DJ, Bache RJ.
    Circulation; 1995 Mar 01; 91(5):1560-7. PubMed ID: 7867199
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
    Verheggen R, Schrör K.
    Biomed Biochim Acta; 1988 Mar 01; 47(10-11):S264-7. PubMed ID: 3248112
    [Abstract] [Full Text] [Related]

  • 27. Interaction of epoprostenol (PGI2) with vasoconstrictors on diameter of large coronary arteries of the dog.
    Dusting GJ, Angus JA.
    J Cardiovasc Pharmacol; 1984 Mar 01; 6(1):20-7. PubMed ID: 6199604
    [Abstract] [Full Text] [Related]

  • 28. Vasomotor activity of moderately well-developed canine coronary collateral circulation.
    Hautamaa PV, Dai XZ, Homans DC, Bache RJ.
    Am J Physiol; 1989 Mar 01; 256(3 Pt 2):H890-7. PubMed ID: 2466413
    [Abstract] [Full Text] [Related]

  • 29. Vasomotor responses of newly developed coronary collateral vessels.
    Kinn JW, Altman JD, Chang MW, Bache RJ.
    Am J Physiol; 1996 Aug 01; 271(2 Pt 2):H490-7. PubMed ID: 8770088
    [Abstract] [Full Text] [Related]

  • 30. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
    Ashton JH, Ogletree ML, Michel IM, Golino P, McNatt JM, Taylor AL, Raheja S, Schmitz J, Buja LM, Campbell WB.
    Circulation; 1987 Oct 01; 76(4):952-9. PubMed ID: 3652429
    [Abstract] [Full Text] [Related]

  • 31. Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo.
    Bove AA, Safford RE, Brum JM, Sufan Q, Dewey JD.
    Prostaglandins; 1986 Nov 01; 32(5):665-77. PubMed ID: 3823487
    [Abstract] [Full Text] [Related]

  • 32. Regulation of coronary blood flow during exercise.
    Duncker DJ, Bache RJ.
    Physiol Rev; 2008 Jul 01; 88(3):1009-86. PubMed ID: 18626066
    [Abstract] [Full Text] [Related]

  • 33. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.
    Kromer BM, Tippins JR.
    Br J Pharmacol; 1996 Nov 01; 119(6):1276-80. PubMed ID: 8937734
    [Abstract] [Full Text] [Related]

  • 34. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium.
    Traverse JH, Judd D, Bache RJ.
    Circulation; 1996 Feb 01; 93(3):558-66. PubMed ID: 8565176
    [Abstract] [Full Text] [Related]

  • 35. Vasopressin and the mature coronary collateral circulation.
    Peters KG, Marcus ML, Harrison DG.
    Circulation; 1989 Jun 01; 79(6):1324-31. PubMed ID: 2720931
    [Abstract] [Full Text] [Related]

  • 36. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region.
    Traverse JH, Kinn JW, Klassen C, Duncker DJ, Bache RJ.
    J Am Coll Cardiol; 1998 Jan 01; 31(1):67-74. PubMed ID: 9426020
    [Abstract] [Full Text] [Related]

  • 37. Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production.
    Klassen CL, Traverse JH, Bache RJ.
    Am J Physiol; 1999 Sep 01; 277(3):H918-23. PubMed ID: 10484411
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.